Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-210-874F-C100 - Provider product page
- Provider
- Enzo Life Sciences
- Product name
- Toll-like receptor 7 polyclonal antibody (FITC conjugate)
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Protein G-affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Green dye
- Vial size
- 100 μg
- Storage
- +4°C
- Handling
- Do not freeze. Protect from light.
Submitted references Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract.
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling.
Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice.
Toll-like receptor-7 modulates immune complex glomerulonephritis.
Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad.
Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line.
TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
Palladino MA, Johnson TA, Gupta R, Chapman JL, Ojha P
Biology of reproduction 2007 Jun;76(6):958-64
Biology of reproduction 2007 Jun;76(6):958-64
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
Smith EB, Schwartz M, Kawamoto H, You X, Hwang D, Liu H, Scherr DS
The Journal of urology 2007 Jun;177(6):2347-51
The Journal of urology 2007 Jun;177(6):2347-51
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling.
Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM
The Journal of cell biology 2007 Apr 23;177(2):265-75
The Journal of cell biology 2007 Apr 23;177(2):265-75
Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice.
Patole PS, Pawar RD, Lech M, Zecher D, Schmidt H, Segerer S, Ellwart A, Henger A, Kretzler M, Anders HJ
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006 Nov;21(11):3062-73
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006 Nov;21(11):3062-73
Toll-like receptor-7 modulates immune complex glomerulonephritis.
Pawar RD, Patole PS, Zecher D, Segerer S, Kretzler M, Schlöndorff D, Anders HJ
Journal of the American Society of Nephrology : JASN 2006 Jan;17(1):141-9
Journal of the American Society of Nephrology : JASN 2006 Jan;17(1):141-9
Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad.
François S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA, Elbim C
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3633-42
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3633-42
Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line.
Srivastava MD, Srivastava BI
Leukemia research 2005 Jul;29(7):813-20
Leukemia research 2005 Jul;29(7):813-20
TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM
Journal of immunology (Baltimore, Md. : 1950) 2005 Aug 1;175(3):1636-42
Journal of immunology (Baltimore, Md. : 1950) 2005 Aug 1;175(3):1636-42
No comments: Submit comment
No validations: Submit validation data